Prof. Dr. Gulfaraz  Khan
My Social Links

Prof. Dr. Gulfaraz Khan

Research Scientist
United Arab Emirates University, United Arab Emirates


Highest Degree
Ph.D. in Medical and Molecular Virology from University of London, UK

Share this Profile

Biography

Dr. Khan is a Professor of Viral Pathology and Chair of the Department of Microbiology & Immunology, College of Medicine and Health Sciences, UAE University (UAEU). He did his undergraduate and postgraduate training in London, followed by postdoctoral training at Tufts University School of Medicine, USA and then LRF Virus Centre, University of Glasgow. He is a Fellow of the Royal College of Pathologists (FRCPath) (UK) and has held faculty positions in universities in UK before moving to his current post in UAE University. Dr Khan’s primary research interest is EBV and association diseases. His secondary interest is in emerging viral infections and public health. He has over 95 original papers, reviews and book chapters, with total citations of nearly 23,000. Recently he was elected to UAE’s Mohammed bin Rashid Academy of Scientists. He also serves on the editorial board of several international journals, including PloS One and Virology Journal.

Area of Interest:

Biomedical Sciences
100%
Oncogenic Viruses
62%
Tumor Biology
90%
Public Health
75%
Virology
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Hassan, Z., P.S. Philip and G. Khan, 2022. The impact of deleting stem-loop 1 of epstein–barr virus-encoded rna 1 on cell proliferation. Viruses, Vol. 14. 10.3390/v14112538.
    CrossRef  |  Direct Link  |  
  2. Hassan, Z., N.D. Kumar, F. Reggiori and G. Khan, 2021. How viruses hijack and modify the secretory transport pathway. Cells, Vol. 10. 10.3390/cells10102535.
    CrossRef  |  Direct Link  |  
  3. Ahmed, W., Z. Hassan, Y.A.A. Abdelmowla, P.S. Philip, A. Shmygol and G. Khan, 2021. Epstein-Barr virus noncoding small RNA (EBER1) induces cell proliferation by up-regulating cellular mitochondrial activity and calcium influx. Virus Res. Vol. 305. 10.1016/j.virusres.2021.198550.
    CrossRef  |  Direct Link  |  
  4. Khan, G., C. Fitzmaurice, M. Naghavi and L.A. Ahmed, 2020. Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990–2017. BMJ Open, Vol. 10. 10.1136/bmjopen-2020-037505.
    CrossRef  |  Direct Link  |  
  5. Hassani, A. and G. Khan, 2020. Human-animal interaction and the emergence of SARS-CoV-2. JMIR Pub. Health Surveill, Vol. 6. 10.2196/22117.
    CrossRef  |  Direct Link  |  
  6. Khan, G. and A. Hassani, 2019. Epstein-Barr Virus in Multiple Sclerosis. In: Multiple Sclerosis. Baloyannis, S.J. (Ed.)., IntechOpen, U.k., pp: 128.
    CrossRef  |  Direct Link  |  
  7. Hassani, A. and G. Khan, 2019. Epstein-barr virus and mirnas: partners in crime in the pathogenesis of multiple sclerosis? Front. Immunol. Vol. 10. 10.3389/fimmu.2019.00695.
    CrossRef  |  Direct Link  |  
  8. Hashim, M.J., F.A. Al-Shamsi, N.A. Al-Marzooqi, S.S. Al-Qasemi, A.H. Mokdad and G. Khan, 2019. Burden of breast cancer in the arab world: findings from global burden of disease, 2016. J. Epidemiol. Global Health Vol. 8. 10.2991/j.jegh.2018.09.003.
    CrossRef  |  Direct Link  |  
  9. Hassani, A., J.R. Corboy, S. Al-Salam and G. Khan, 2018. Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells. PLoS ONE, Vol. 13. 10.1371/journal.pone.0192109.
    CrossRef  |  Direct Link  |  
  10. Ahmed, W., S. Tariq and G. Khan, 2018. Tracking EBV-encoded RNAs (EBERs) from the nucleus to the excreted exosomes of B-lymphocytes. Sci. Rep. Vol. 8. 10.1038/s41598-018-33758-4.
    CrossRef  |  Direct Link  |